An obesity medicine doctor and author invites followers to share the myths they keep hearing, with no specific claim or new detail attached.
Recap by typeshit. Post by @drsalaswhalen on Instagram.
8:09
Regan Archibald gives his take on the timeline for retatrutide reaching patients. Tap through for his view on where the drug stands.
Morse says bar and restaurant workers have seen younger adults drink less, framing it as a broad change in the alcohol industry.
Bazaar India's new issue looks at collagen loss and skin laxity concerns tied to fast GLP-1 weight loss, and how beauty brands are responding.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Fifteen drugs, from Ozempic and Wegovy to Trelegy Ellipta, get Medicare negotiated prices that take effect January 1, 2027.
Washington Times asks physicians about the growing talk of GLP-1 drugs as an anti-aging fix, and they urge caution before reading too much into it.
Loading…